Trademark: DAPAVELDACTIN
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for DAPAVELDACTIN
We do not have any records of a proof of use for DAPAVELDACTIN at this moment.
Possible trademark infringements of DAPAVELDACTIN
Basic Information about DAPAVELDACTIN
- Serial Number
- 86660842
- Filing Date
- 12 Jun 2015
- Registration Number
- 5167106
- Registration Date
- 21 Mar 2017
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of DAPAVELDACTIN on the blockchain with WikiTrademarks.io.
- First use of DAPAVELDACTIN anywhere
- DAPAVELDACTIN was first used on 01 Sep 2016 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns DAPAVELDACTIN?
1. Liptis Pharmaceuticals USA, Inc. Spring Valley NY
2. Liptis Pharmaceuticals USA, Inc. Spring Valley NY
3. Liptis Pharmaceuticals USA, Inc. Spring Valley NY
Correspondent
- Brian A. Bloom
- Moritt Hock & Hamroff Llp
- 1407 Broadway
- New York NY 10018
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io